Telomir Pharmaceuticals, Inc. appointed Andriy Mushak as its fractional Chief Financial Officer, effective June 6, 2026, replacing Alan Weichselbaum. Mr. Mushak will be paid $6,000 per month for his services through a consulting agreement with LMAM Consulting Group, LLC.
